CMGVX | RPMGX | CMGVX / RPMGX | |
Total Expense Ratio | 0.83 | 0.75 | 111% |
Annual Report Gross Expense Ratio | 0.84 | 0.75 | 112% |
Fund Existence | 15 years | 33 years | - |
Gain YTD | 17.971 | 2.467 | 729% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.88B | 26.1B | 7% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 11.29 | -7.46 | -151% |
Returns for 3 years | 67.36 | 18.94 | 356% |
Returns for 5 years | 1.76 | -4.20 | -42% |
Returns for 10 years | 8.44 | 28.78 | 29% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GOOX | 47.62 | 0.52 | +1.10% |
T-Rex 2X Long Alphabet Daily Target ETF | |||
AVMU | 46.06 | 0.01 | +0.03% |
Avantis Core Municipal Fixed Inc ETF | |||
FLCO | 21.98 | -0.02 | -0.08% |
Franklin Investment Grade Corporate ETF | |||
XBI | 107.80 | -0.11 | -0.10% |
SPDR® S&P Biotech ETF | |||
IBGB | 25.47 | -0.06 | -0.24% |
iShares iBonds Dec 2045 Term Trsy ETF |